PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Other Accumulated Expenses (2021 - 2026)

PepGen (PEPG) posted Other Accumulated Expenses of $2.4 million for Q1 2026, up 1105.94% sequentially from $202000.0 in Q4 2025, and down 78.75% YoY from $11.5 million in Q1 2025.

Analysis

PepGen (PEPG) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

PepGen has reported Other Accumulated Expenses for 6 years, with the latest figure at $2.4 million in Q1 2026.

  • Quarterly Other Accumulated Expenses fell 78.75% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 78.75% YoY) and the FY2025 annual result came in at $202000.0, down 97.07% from the prior year.
  • Other Accumulated Expenses improved to $2.4 million in Q1 2026 per PEPG's latest filing, from $202000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $11.5 million in Q1 2025 and troughed at $202000.0 in Q4 2025.
  • A 5-year average of $3.2 million and a median of $1.6 million in 2022 frame the typical range for Other Accumulated Expenses.
  • The widest YoY moves for Other Accumulated Expenses: up 1103.99% in 2025, down 97.07% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $1.1 million in 2022, then decreased by 18.54% to $918000.0 in 2023, then surged by 651.96% to $6.9 million in 2024, then tumbled by 97.07% to $202000.0 in 2025, then surged by 1105.94% to $2.4 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.4 million, $202000.0, and $476000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 PepGen 217.99 Mn 217.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
Mar 31, 2026 2.44 Mn
Dec 31, 2025 2.99 Mn
Sep 30, 2025 4.21 Mn
Jun 30, 2025 8.90 Mn
Mar 31, 2025 11.46 Mn
Dec 31, 2024 6.90 Mn
Sep 30, 2024 2.68 Mn
Jun 30, 2024 7.43 Mn
Mar 31, 2024 4.05 Mn
Dec 31, 2023 9.52 Mn
Sep 30, 2023 10.27 Mn
Jun 30, 2023 5.96 Mn
Mar 31, 2023 6.96 Mn
Dec 31, 2022 4.84 Mn
Sep 30, 2022 3.50 Mn
Jun 30, 2022 8.50 Mn
Mar 31, 2022 7.72 Mn
Dec 31, 2021 5.34 Mn